Gradient performance in tumor characterization at Vanderbilt University Institute
- Featuring
- March 13 2025
- Duration 2: 47
Dr. Junzhong Xu, director of Cancer Imaging Research at the Vanderbilt University Institute of Imaging Science, discusses the development of MR cell size imaging1 utilizing diffusion MRI. The imaging technique provides real-time data on cell size, density and membrane permeability and gradient strength is crucial for accurate measurements. The technology's ability to differentiate recurrent brain tumors from radiation injuries and track cell changes associated with chemotherapy-induced apoptosis is groundbreaking. Watch this video with Dr. Xu to learn more.
At-a-glance:
- Hear how Vanderbilt is able to detect change in tumor morphology to provide a much earlier response
- See how a technology is used that provides cell size, cell density and membrane permeability information to know the exact response of cancer cells to distinguish recurring brain tumors from radiation induced injuries
Our ability to detect accurate mean cell size in tumors relies on the gradient strength we have. The stronger gradients we have, the more accurate and reliable measurements we can make.
Junzhong Xu, PhD
Director of Cancer Imaging Research
Vanderbilt University Institute of Imaging Science
Copy this URLto share this story with your professional network
Sign up for news and updates
Footnotes
- MR cell size imaging is being developed by the VUIIS and is not a product.
Disclaimer
Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions. Results in other cases may vary.